Management of Orthostatic Hypotension
The first-line treatment for orthostatic hypotension should be non-pharmacological approaches, including physical counter-pressure maneuvers, compression garments, increased salt and fluid intake, small frequent meals, and elevating the head of bed during sleep. 1
Definition and Diagnosis
Orthostatic hypotension is defined as:
- Decrease in systolic blood pressure ≥20 mmHg or diastolic ≥10 mmHg within 3 minutes of standing from a seated or supine position 1, 2, 3
- Diagnosis requires measuring blood pressure after 5 minutes of lying/sitting, then at 1 and 3 minutes after standing 1
- Common symptoms include dizziness, lightheadedness, blurred vision, weakness, fatigue, and less commonly syncope and coat hanger pain (neck/shoulder pain) 1, 3
Treatment Algorithm
Step 1: Non-pharmacological Approaches (First-line)
- Physical counter-pressure maneuvers (leg crossing, squatting)
- Compression garments (waist-high stockings)
- Increased salt and fluid intake (note: water alone can increase systolic BP by >30 mmHg in many patients) 1, 4
- Small, frequent meals to avoid postprandial hypotension
- Elevating the head of bed during sleep (10-20°)
- Regular exercise to prevent deconditioning 1
Important note: Interestingly, drinking plain water (480 mL) can provide a significant acute pressor response and may be more effective than salt water for immediate BP elevation 5, 4. Water drinking can increase standing BP from 83/53 mmHg to 114/66 mmHg within 35 minutes 4.
Step 2: Medication Review and Adjustment
- Identify and discontinue medications that worsen orthostatic hypotension 1, 6:
- Antihypertensives (especially alpha-1 blockers, centrally acting agents)
- Psychiatric medications (phenothiazines, tricyclic antidepressants, MAOIs)
- Opioids
- Anticholinergics
- Diuretics (if causing volume depletion)
Step 3: Pharmacological Treatment
If symptoms persist despite non-pharmacological measures:
Fludrocortisone (0.05-0.1 mg daily, titrated to 0.1-0.3 mg daily) 1
- Promotes sodium retention and vessel wall constriction
- Use with caution in patients with heart failure or renal impairment
Droxidopa (100-600 mg three times daily) 1, 3
- FDA-approved for neurogenic orthostatic hypotension
- Last dose at least 4 hours before bedtime
Monitoring and Follow-up
- Regular BP measurements in supine and standing positions to assess treatment effectiveness 1
- Monitor for supine hypertension, especially with pressor medications 1, 7
- Follow-up every 3 months once stabilized 1
- For patients on midodrine, assess for symptomatic improvement and continue only if significant benefit is reported 7
Special Considerations
- Target BP goal: Minimize postural symptoms rather than restore normotension 1
- Supine hypertension management: Prevent full supine position by elevating head of bed; last dose of pressor medications should be several hours before bedtime 1, 7
- Renal impairment: Use midodrine with caution, starting at lower doses (2.5 mg) 7
- Urinary retention: Use midodrine cautiously in patients with urinary problems as it acts on alpha-adrenergic receptors of the bladder neck 7
- Drug interactions: Avoid concomitant use of midodrine with other vasoconstrictors, MAO inhibitors, or cardiac glycosides 7
When to Refer to a Specialist
Referral is necessary for:
- Refractory hypotension despite initial management
- Suspected secondary causes
- Hypotension with multiple cardiovascular risk factors 1